[en] Colorectal cancer is the most frequent digestive cancer. Prognosis is greatly depending on the TNM stage at the time of diagnosis. Fifty percent of all patients shall develop, synchronously or metachronously, liver metastases. Different means such as chemotherapy, targeted therapies, radiofrequency ablation, portal vein embolization and two-stage hepatectomy may be used to make these metastases eventually resectable and to increase overall survival. This is a short review of these different methods used to increase resectability but also on the integration of these parameters in a larger approach of colorectal liver metastasis surgery especially insisting on multidisciplinary discussion.
Disciplines :
Gastroenterology & hepatology Oncology Surgery
Author, co-author :
Gilson, Nathalie
Honore, Charles ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie abdominale- endocrinienne et de transplantation
Detry, Olivier ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie abdominale- endocrinienne et de transplantation
De Roover, Arnaud ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie abdominale- endocrinienne et de transplantation
Coimbra Marques, Carla ; Université de Liège - ULiège > Chirurgie abdominale- endocrinienne et de transplantation
Kohnen, Laurent ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie abdominale- endocrinienne et de transplantation
Polus, Marc ; Centre Hospitalier Universitaire de Liège - CHU > Gastro-Entérologie-Hépatologie
Piront, Patricia ; Centre Hospitalier Universitaire de Liège - CHU > Gastro-Entérologie-Hépatologie
Van Daele, Daniel ; Centre Hospitalier Universitaire de Liège - CHU > Gastro-Entérologie-Hépatologie
Honore, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie abdominale- endocrinienne et de transplantation
Meurisse, Michel ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie abdominale- endocrinienne et de transplantation
Language :
English
Title :
Surgical management of hepatic metastases of colorectal origin.
GARDEN O.J., REES M., POSTON G.J., MIRZA D., SAUNDERS M., LEDERMANN J., PRIMROSE J.N., PARKS R.W. Guidelines for resection of colorectal cancer liver metastases. Gut, 2006, 55 Suppl 3iii : 1-8.
SCHEELE J., STANGL R., ALTENDORF-HOFMANN A. et al. Resection of colorectal liver metastases. World J. Surg., 1995, 19 : 59-71.
SCHEELE J., STANGL R., ALTENDORF-HOFMANN A. Hepatic metastases from colorectal carcinoma : impact of surgical resection on the natural history. Br. J. Surg., 1990, 77 : 1241-1246
STANGL R., ALTENDORF-HOFMANN A., CHARNLEY R.M. et al. Factors influencing the natural history of colorectal liver metastases. Lancet, 1994, 343 : 1405-1410
SUGERBAKER PH. Surgical decision making for large bowel cancer metastatic to the liver. Radiology, 1990, 174 : 621-626
ADAM R. Liver met survey. European registry of hepatic metastasis of colorectal origin. First International registry of patients undergoing surgery for hepatic metastases from colorectal cancer. www.livermetsurvey.org Dec, 2007.
WICHERTS D.A., DE HAAS R.J., ADAM R. Bringing unresectable liver disease to resection with curative intent. Eur. J. Surg. Oncol., 2007, 33 Suppl 2 : S42-51.
GIACCHETTI S., ITZHAKI M., GRUIA G., ADAM R., ZIDANI R.. KUNSTLINGER F., BRIENZA S., ALAFACI E., BERTHEAULT-CVITKOVIC F., JASMIN C., REYNES M., BISMUTH H., MISSET J.L., LÉVI F. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann. Oncol., 1999, 10 : 663-669
ADAM R., VIBERT E., PITOMBO M. Induction chemotherapy and surgery of colorectal liver metastases. Bull Cancer, 2006, 93 Suppl 1 : S45-9.
POSTON G.J., FIGUERAS J., GIULIANTE F., NUZZO G., SOBRERO A.F., GIGOT J.F., NORDLINGER B., ADAM R., GRUENBERGER T., CHOTI M.A., BILCHIK A.J., VAN CUTSEM E.J.D., CHIANG J.M., D'ANGELICA M.I. Urgent need for a new staging system in advanced colorectal cancer. J. Clin. Oncol., 2008, 26 : 4828-4833
KHATRI V.P., PETRELLI N.J., BELGHITI J. Extending the frontiers of surgical therapy for hepatic colorectal metastases : is there a limit ? J. Clin. Oncol, 2005, 23 : 8490-8499
ABDALLA E.K., ADAM R., BILCHIK A.J., JAECK D., VAUTHEY J.N., MAHVI D. Improving resectability of hepatic colorectal metastases : expert consensus statement. Ann. Surg. Oncol., 2006, 13 : 1271-1280
FONG Y., FORTNER J., SUN R.L., BRENNAN M.F., BLUMGART L.H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer : analysis of 1001 consecutive cases. Ann. Surg., 1999, 230 : 309-18, discussion 318-321
MILLER G., BIERNACKI P., KEMENY N.E., GONEN M., DOWNEY R., JARNAGIN W.R., D'ANGELICA M., FONG Y., BLUMGART L.H., DEMATTEO R.P. Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J. Am. Coll. Surg., 2007, 205 : 231-238
KANEMITSU Y., KATO T., HIRAI T., YASUI K. Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer. Br. J. Surg., 2004, 91 : 112-120
YAMAKADO K.. HASE S., MATSUOKA T. TANIGAWA N., NAKATSUKA A., TAKAKI H., TAKAO M., INOUE Y., KANAZAWA S., INOUE Y., SAWADA S., KUSUNOKI M., TAKEDA K. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer : a multicenter study in Japan. J. Vasc. Interv. Radiol., 2007, 18 : 393-398
FFCD. Que faire devant un cancer digestif en, 2008 ? Recommandations de la Fédération Francophone de Cancérologie Digestive. www.ffcd.fr
ERROI F., SCARPA M., ANGRIMAN I., CECCHETTO A., PASETTO L., MOLLICA E., BETTIOL M., RUFFOLO C., POLESE L., CILLO U., D'AMICO D.F. Ovarian metastasis from colorectal cancer : prognostic value of radical oophorectomy. J. Surg. Oncol., 2007, 96 : 113-117
GOÉRÉ D., DAVEAU C., ELIAS D., BOIGE V., TOMASIC G., BONNET S., POCARD M., DROMAIN C., DUCREUX M., LASSER P., MALKA D. The differential response to chemotherapy of ovarian metastases from colorectal carcinoma. Eur. J. Surg. Oncol., 2008, 34 : 1335-1339
ELIAS D., POCARD M., GOERE D. HIPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin. Cancer Treat. Res., 2007, 134 : 303-318
ELIAS D., BENIZRI E., POCARD M., DUCREUX M., BOIGE V., LASSER P. Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer. Eur. J. Surg. Oncol., 2006, 32 : 632-636
ADAM R., DE HAAS R.J., WICHERTS D.A., ALOIA T.A., DELVART V., AZOULAY D., BISMUTH H., CASTAING D. Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement ? J. Clin. Oncol, 2008, 26 : 3672-3680
ELIAS D., LIBERALE G., VERNEREY D., POCARD M., DUCREUX M., BOIGE V., MALKA D., PIGNON J.P., LASSER P. Hepatic and extrahepatic colorectal metastases : when resectable, their localization does not matter, but their total number has a prognostic effect. Ann. Surg. Oncol., 2005, 12 : 900-9.
MOURRA N., HOEFFEL C., DUVILLARD P., GUETTIER C., FLEJOU J.F., TIRET E. Adrenalectomy for Clinically Isolated Metastasis from Colorectal Carcinoma : Report of Eight Cases. Dis. Colon Rectum, 2008, 51 : 1846-1849
KIM S.H., BRENNAN M.F., RUSSO P., BURT M.E., COIT D.G. The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer, 1998, 82 : 389-394
GASENT BLESA J.M., DE LA MORENA E., LAFORGA CANALES J.B., VILASECA MARTÍNEZ D., VÁZQUEZ C. Clinical case report and literature review : metachronous colorectal splenic metastases. Clin. Transl. Oncol., 2008, 10 : 445-447
WICHERTS D.A., DE HAAS R.J., ADAM R. Bringing unresectable liver disease to resection with curative intent. Eur. J. Surg. Oncol., 2007, 33 (Suppl2) : S42-51.
FALCONE A., RICCI S., BRUNETTI I., PFANNER E., ALLEGRINI G., BARBARA C., CRINÒ L., BENEDETTI G., EVANGELISTA W., FANCHINI L., CORTESI E., PICONE V., VITELLO S., CHIARA S., GRANETTO C., PORCILE G., FIORETTO L., ORLANDINI C., ANDREUCCETTI M., MASI G, GRUPPO ONCOLOGICO NORD OVEST. Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer : the Gruppo Oncologico Nord Ovest. J. Clin. Oncol., 2007, 25 : 1670-1676
MASI G., CUPINI S., MARCUCCI L., CERRI E., LOUPAKIS F., ALLEGRINI G., BRUNETTI IM., PFANNER E., VITI M., GOLETTI O., FILIPPONI F., FALCONE A. Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer. Ann. Surg. Oncol., 2006, 13 : 58-65.
NORDLINGER B., SORBYE H., COLLETTE L., GLIMELIUS B., POSTON G.J., SCHLAG P.M. et al. Final results of the EORTC Intergroup randomized phase III study 40983 (EPOC) evaluating the benefit of perioperative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases. J. Clin. Oncol., 2007, 25 (Suppl 18S) : LBA5.
BOIGE V., MALKA D., ELIAS D., CASTAING M., DE BAERE T., GOERE D., DROMAIN C., POCARD M., DUCREUX M. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure. Ann. Surg. Oncol., 2008, 15 : 219-226
ELIAS D., GOERE D., BOIGE V., KOHNEH-SHARHI N., MALKA D., TOMASIC G., DROMAIN C., DUCREUX M. Outcome of posthepatectomy-missing colorectal liver metastases after complete response to chemotherapy : impact of adjuvant intra-arterial hepatic oxaliplatin. Ann. Surg. Oncol., 2007, 14 : 3188-3194
DUCREUX M., YCHOU M., LAPLANCHE A., GAMELIN E., LASSER P., HUSSEINI F., QUENET F., VIRET F., JACOB JH., BOIGE V., ELIAS D., DELPERRO J.R., LUBOINSKI M., GASTROINTESTINAL GROUP OF THE FEDERATION NATIONALE DES CENTRES DE LUTTE CONTRE LE CANCER. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases : a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. J. Clin. Oncol., 2005, 23 : 4881-4887
ERIGUCHI M., LEVI F., HISA T., YANAGIE H., NONAKA Y., TAKEDA Y. Chronotherapy for cancer. Biomed. Pharmacother., 2003, 57 Suppl 1 : 92s-95s.
LÉVI F., FOCAN C., KARABOUÉ A., DE LA VALETTE V., FOCAN-HENRARD D., BARON B., KREUTZ F., GIACCHETTI S. Implications of circadian docks for the rhythmic delivery of cancer therapeutics. Adv. Drug Deliv. Rev., 2007, 59 : 1015-1035
ADAM R., ALOIA T., LÉVI F., WICHERTS D.A., DE HAAS R.J., PAULE B., BRALET M.P., BOUCHAHDA M., MACHOVER D., DUCREUX M., CASTAGNE V., AZOULAY D., CASTAING D. Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J. Clin. Oncol., 2007, 25 : 4593-4602
VAN CUTSEM E., NOWACKI M., LANG I., CASCINU S., SHCHEPOTIN I., MAUREL J., ROUGIER P., CUNNINGHAM D., NIPPGEN J., KÖHNE C. Randomized phase III study of irinotecan and 5-FU/FA with or without cetuximab in the first-line treatment of patients with metastatic colorectal cancer (mCRC) : The CRYSTAL trial. J. Clin. Oncol., 2007, 25 (Suppl) : 18S.
BOKEMEYER C., BONDARENKO I., HARTMANN J.T., DE BRAND F.G., VOLOVAT C., NIPPGEN J., STROH C., CELIK I., KORALEWSKI P. KRAS status and efficacy of first-line treatment of patients with metastatic colorectal cancer (mCRC) with FOLFOX with or without cetuximab : the Opus experience. J. Clin. Oncol., 2008, 26 (Suppl) : 2008 (abstr 4000).
ELIAS D., SANTORO R., OUELLET J.F., OSMAK L., DE BAERE T., ROCHE A. Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases. Hepatogastroenterology, 2004, 51 : 1788-1791
ELIAS D.. BATON O., SIDERIS L., MATSUHISA T., POCARD M., LASSER P. Local recurrences after intraoperative radiofrequency ablation of liver metastases : a comparative study with anatomic and wedge resections. Ann. Surg. Oncol., 2004, 11 : 500-505
HUBERT C., GRAS J., GOFFETTE P., GRAJEDA J.M., VAN BEERS B.E., LAURENCE A., HORSMANS Y., SEMPOUX C., RAHIER J., ZECH F., GIGOT J.F. Percutaneous and surgical radiofrequency ablation of liver malignancies : a single institutional experience. Acta Gastroenterol. Belg., 2007, 70 : 188-194
ADAM R., MILLER R., PITOMBO M., WICHERTS D.A., DE HAAS R.J., BITSAKOU G., ALOIA T. Two-stage Hepatectomy Approach for Initially Unresectable Colorectal Hepatic Metastases. Surg. Oncol. Clin. N. Am., 2007, 16 : 525-536
AZOULAY D., CASTAING D., SMAIL A., ADAM R., CAILLIEZ V., LAURENT A., LEMOINE A., BISMUTH H. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann. Surg., 2000, 231 : 480-486
AZOULAY D., CASTAING D., SMAIL A., ADAM R., CAILLIEZ V., LAURENT A., LEMOINE A., BISMUTH H. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann. Surg., 2000, 231 : 480-486
JAECK D., OUSSOULTZOGLOU E., ROSSO E., GREGET M., WEBER J.C., BACHELLIER P. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann. Surg., 2004, 240 : 1037-1049
TOGO S., NAGANO Y., MASUI H., TANAKA K., MIURA Y., MORIOKA D., ENDO I., SEKIDO H., IKE H., SHIMADA H. Two-stage hepatectomy for multiple bilobular liver metastases from colorecal cancer. Hepatogastroenterology, 2005, 52 : 913-919 (Pubitemid 40834631)
AZOULAY D., ANDREANI P., MAGGI U., SALLOUM C., PERDIGAO F., SEBAGH M., LEMOINE A., ADAM R., CASTAING D. Combined liver resection and reconstruction of the supra-renal vena cava : the Paul Brousse experience. Ann. Surg., 2006, 244 : 80-8. Erratum in : Ann. Surg., 2007 May, 245 (5)
AZOULAY D., ESHKENAZY R., ANDREANI P., CASTAING D., ADAM R., ICHAI P., NAILI S., VINET E., SALIBA F., LEMOINE A., GILLON M.C., BISMUTH H. In situ hypothermic perfusion of the liver versus standard total vascular exclusion for complex liver resection. Ann. Surg., 2005, 241 : 277-285
MENTHA G., MAJNO P.E., ANDRES A., RUBBIA-BRANDT L., MOREL P., ROTH A.D. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br. J. Surg., 2006, 93 : 872-878
HONORÉ C., DETRY O., DE ROOVER A., MEURISSE M., HONORÉ P. Liver transplantation for metastatic colon adenocarcinoma : report of a case with 10 years of follow-up without recurrence. Transpl. Int., 2003, 16 : 692-3.
ADAM R., MILLER R., PITOMBO M., WICHERTS D.A., DE HAAS R.J., BITSAKOU G., ALOIA T. ADAM R., PASCAL G., CASTAING D., AZOULAY D., DELVART V., PAULE B., LEVI F., BISMUTH H. Tumor progression while on chemotherapy : a contraindication to liver resection for multiple colorectal metastases ? Ann. Surg., 2004, 240 : 1052-61, discussion 1061-1064
BENOIST S., BROUQUET A., PENNA C., JULIÉ C., EL HAJJAM M., CHAGNON S., MITRY E., ROUGIER P., NORDLINGER B. Complete response of colorectal liver metastases after chemotherapy : does it mean cure ? J. Clin. Oncol., 2006, 24 : 3939-3945
VAUTHEY J.N., PAWLIK T.M., RIBERO D., WU T.T. ZORZI D., HOFF P.M., XIONG H.Q., ENG C., LAUWERS G.Y., MINOKENUDSON M., RISIO M., MURATORE A., CAPUSSOTTI L., CURLEY S.A., ABDALLA E.K. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J. Clin. Oncol., 2006, 24 : 2065-2072
ALOIA T., SEBAGH M., PLASSE M., KARAM V., LÉVI F., GIACCHETTI S., AZOULAY D., BISMUTH H., CASTAING D., ADAM R. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J. Clin. Oncol, 2006, 24 : 4983-4990
ZORZI D., LAURENT A., PAWLIK T.M., LAUWERS G.Y., VAUTHEY J.N., ABDALLA E.K. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br. J. Surg., 2007, 94 : 274-286
BIRKMEYER J.D., SIEWERS A.E., FINLAYSON E.V., STUKEL T.A., LUCAS F.L., BATISTA I., WELCH H.G., WENNBERG D.E. Hospital volume and surgical mortality in the United States. N. Engl. J. Med., 2002, 346 : 1128-1137
LAURENT C., SA CUNHA A., COUDERC P., RULLIER E., SARIC J. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br. J. Surg., 2003, 90 : 1131-1136
DIMICK J.B., COWAN J.A.J., KNOL J.A., UPCHURCH G.R. JR. Hepatic resection in the United States : indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch. Surg., 2003, 138 : 185-191
CHICHE L. Quelles métastases hépatiques sont résécables d'emblée ? Gastroenterol. Clin. Biol., 2003, 27 (suppl2) : B41-B62.
Service Demographique de la DG Statistique du SPF Economie Juillet, 2005. Evolution de l'espérance de vie-Royaume et régions (2002-2003).
FIGUERAS J., RAMOS E., LOPEZ-BEN S., TORRAS J., ALBIOL M., LLADO L., GONZALEZ HD., RAFECAS A. Surgical treatment of liver metastases from colorectal carcinoma in elderly patients. When is it worthwhile ? Clin. Transl. Oncol., 2007 Jun, 9 (6) : 392-400.
ROTHBARTH J., PIJL M.E., VAHRMEIJER A.L., HARTGRINK H.H., TIJL F.G., KUPPEN P.J., TOLLENAAR R.A., VAN DE VELDE C.J. Isolated hepatic perfusion with high-dose melphalan for the treatment of colorectal metastasis confined to the liver. Br. J. Surg., 2003, 90 : 1391-1397
AUGUSTINE J.J., BODZIAK K.A., HRICIK D.E. Use of sirolimus in solid organ transplantation. Drugs, 2007, 67 : 369-391 (Pubitemid 46425551)
DOCKX O., TROISI R., BALDUCCI G., GEUBEL A., RAHIER J., DE HEMPTINNE B.. DE VILLE DE GOYET J., KESTENS P.J., OTTE J.B. Role of liver transplantation in the treatment of metastatic disease of the liver. Acta Chir. Belg., 1992, 92 : 164-167
SMITH R.A., STUBBLEHELD G.C., REAGAN M.T. Effective palliation of metastatic adenocarcinoma of the liver : a case report. J. Miss State Med. Assoc, 1988, 29 : 301-304
European liver transplantation registry (ELTR) : www.eltr.org
